This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matsumura, N. Articles by Ihara, Y. Search for Related Content PubMed PubMed Citation Articles by Matsumura, N. Articles by Ihara, Y.

(American Journal of Pathology. 1999;154:1649-1656.)
© 1999 American Society for Investigative Pathology

Short Communication

Stable Expression in Chinese Hamster Ovary Cells of Mutated Tau Genes Causing Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 (FTDP-17)

Nobutaka Matsumura^*, Tsuneo Yamazaki^* and Yasuo Ihara^*

From the Department of Neuropathology,^*
Faculty of Medicine, University of Tokyo, Tokyo, and Core Research for Evolutional Science and Technology (CREST),
Japan Science and Technology Corporation, Kawaguchi, Japan

Extensive neuronal loss and aggregation of tau as cytoplasmic inclusions in neurons and glial cells in selected cortical and subcortical regions is the most striking characteristic of frontotemporal dementia and parkinsonism linked to chromosome 17, which is caused by exonic or intronic mutations in the tau gene. Here, we examined the effects of four exonic mutations in four-repeat tau using stably transfected Chinese hamster ovary cells. The proportion of polymerized tubulin was the largest in the P301L transfectant. G272V and P301L transfectants showed greater instability of microtubules in the presence of Colcemid than wild-type tau, V337M, or R406W transfectants. Thus no distinct phenotypes were shared by the mutant tau transfectants with regard to microtubule assembly and stability. Unexpectedly, R406W showed low and negligible levels of phosphorylation at Thr 231 and Ser 396, respectively, in the transfectant. This presents a sharp contrast to the observation that tau aggregates in R406W-affected brains are heavily phosphorylated at these two sites. This result suggests that hyperphosphorylation at these sites cannot occur in the tau R406W bound to microtubules, and thus that the hyperphosphorylated species of tau may be generated only after disruption of microtubules.

This article has been cited by other articles:

				F. Sakaue, T. Saito, Y. Sato, A. Asada, K. Ishiguro, M. Hasegawa, and S.-i. Hisanaga Phosphorylation of FTDP-17 Mutant tau by Cyclin-dependent Kinase 5 Complexed with p35, p25, or p39 J. Biol. Chem., September 9, 2005; 280(36): 31522 - 31529. [Abstract] [Full Text] [PDF]

				M. Ikeda, M. Shoji, T. Kawarai, T. Kawarabayashi, E. Matsubara, T. Murakami, A. Sasaki, Y. Tomidokoro, Y. Ikarashi, H. Kuribara, et al. Accumulation of Filamentous Tau in the Cerebral Cortex of Human Tau R406W Transgenic Mice Am. J. Pathol., February 1, 2005; 166(2): 521 - 531. [Abstract] [Full Text] [PDF]

				A. d. C. Alonso, A. Mederlyova, M. Novak, I. Grundke-Iqbal, and K. Iqbal Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations J. Biol. Chem., August 13, 2004; 279(33): 34873 - 34881. [Abstract] [Full Text] [PDF]

				F. Oyama, S. Kotliarova, A. Harada, M. Ito, H. Miyazaki, Y. Ueyama, N. Hirokawa, N. Nukina, and Y. Ihara Gem GTPase and Tau: MORPHOLOGICAL CHANGES INDUCED BY GEM GTPase IN CHO CELLS ARE ANTAGONIZED BY TAU J. Biol. Chem., June 25, 2004; 279(26): 27272 - 27277. [Abstract] [Full Text] [PDF]

				P. K. Krishnamurthy and G. V. W. Johnson Mutant (R406W) Human Tau Is Hyperphosphorylated and Does Not Efficiently Bind Microtubules in a Neuronal Cortical Cell Model J. Biol. Chem., February 27, 2004; 279(9): 7893 - 7900. [Abstract] [Full Text] [PDF]

				F. Dou, W. J. Netzer, K. Tanemura, F. Li, F. U. Hartl, A. Takashima, G. K. Gouras, P. Greengard, and H. Xu Chaperones increase association of tau protein with microtubules PNAS, January 21, 2003; 100(2): 721 - 726. [Abstract] [Full Text] [PDF]

				M. DeTure, L.-w. Ko, C. Easson, and S.-H. Yen tau Assembly in Inducible Transfectants Expressing Wild-Type or FTDP-17 tau Am. J. Pathol., November 1, 2002; 161(5): 1711 - 1722. [Abstract] [Full Text] [PDF]

				P. Delobel, S. Flament, M. Hamdane, R. Jakes, A. Rousseau, A. Delacourte, J.-P. Vilain, M. Goedert, and L. Buee Functional Characterization of FTDP-17 tau Gene Mutations through Their Effects on Xenopus Oocyte Maturation J. Biol. Chem., March 8, 2002; 277(11): 9199 - 9205. [Abstract] [Full Text] [PDF]

				T. Miyasaka, M. Morishima-Kawashima, R. Ravid, P. Heutink, J. C. van Swieten, K. Nagashima, and Y. Ihara Molecular Analysis of Mutant and Wild-Type Tau Deposited in the Brain Affected by the FTDP-17 R406W Mutation Am. J. Pathol., February 1, 2001; 158(2): 373 - 379. [Abstract] [Full Text] [PDF]

				M. GOEDERT, B. GHETTI, and M. G. SPILLANTINI Tau Gene Mutations in Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 (FTDP-17): Their Relevance for Understanding the Neurogenerative Process Ann. N.Y. Acad. Sci., December 1, 2000; 920(1): 74 - 83. [Abstract] [Full Text] [PDF]

				V. Vogelsberg-Ragaglia, J. Bruce, C. Richter-Landsberg, B. Zhang, M. Hong, J. Q. Trojanowski, and V. M.-Y. Lee Distinct FTDP-17 Missense Mutations in Tau Produce Tau Aggregates and Other Pathological Phenotypes in Transfected CHO Cells Mol. Biol. Cell, December 1, 2000; 11(12): 4093 - 4104. [Abstract] [Full Text]